The Effect of Omalizumab on Airway Responsiveness to Adenosine in Patients With Poorly Controlled Asthma
Status:
Completed
Trial end date:
2006-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether the addition of omalizumab in patients with
poorly controlled asthma (because of poor adherence) will decrease allergic airway
inflammation and improve asthma control.